Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PDE4DIP mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PDE4DIP mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | ISO | Pde4dip (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of PDE4DIP mRNA | CTD | PMID:22206623 | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of PDE4DIP mRNA | CTD | PMID:21983209 | 17alpha-ethynylestradiol | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDE4DIP mRNA | CTD | PMID:17942748 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of PDE4DIP mRNA | CTD | PMID:32145629 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDE4DIP mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pde4dip (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PDE4DIP mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PDE4DIP mRNA | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PDE4DIP mRNA | CTD | PMID:19465110 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of PDE4DIP mRNA | CTD | PMID:21346803 | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of PDE4DIP protein | CTD | PMID:34915118 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PDE4DIP mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Pde4dip (Mus musculus) | 6480464 | bisphenol S results in increased methylation of PDE4DIP exon | CTD | PMID:33297965 | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of PDE4DIP mRNA | CTD | PMID:21346803 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Fenretinide results in decreased expression of PDE4DIP mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Decitabine affects the expression of PDE4DIP mRNA | CTD | PMID:17145863 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of PDE4DIP mRNA | CTD | PMID:36843608 | 7,12-dimethyltetraphene | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:32553695 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of PDE4DIP mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of PDE4DIP mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases methylation | ISO | PDE4DIP (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of PDE4DIP gene | CTD | PMID:27153756 | all-trans-retinoic acid | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [Tretinoin co-treated with arsenic trioxide] affects the expression of PDE4DIP mRNA | CTD | PMID:15894607 | all-trans-retinoic acid | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Tretinoin results in increased expression of PDE4DIP mRNA | CTD | PMID:15894607 and PMID:23724009 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PDE4DIP mRNA | CTD | PMID:16483693 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of PDE4DIP mRNA | CTD | PMID:30779732 | amphotericin B | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Amphotericin B analog results in decreased expression of PDE4DIP mRNA | CTD | PMID:28534445 | antirheumatic drug | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of PDE4DIP mRNA | CTD | PMID:24449571 | arachidonic acid | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Arachidonic Acid results in decreased expression of PDE4DIP mRNA | CTD | PMID:16704987 | arsane | affects methylation | ISO | PDE4DIP (Homo sapiens) | 6480464 | Arsenic affects the methylation of PDE4DIP gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | PDE4DIP (Homo sapiens) | 6480464 | Arsenic affects the methylation of PDE4DIP gene | CTD | PMID:25304211 | arsenite(3-) | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | arsenite affects the expression of PDE4DIP mRNA | CTD | PMID:22959463 | arsenous acid | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] affects the expression of PDE4DIP mRNA | CTD | PMID:15894607 | arsenous acid | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of PDE4DIP mRNA | CTD | PMID:15761015 | benzo[a]pyrene | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PDE4DIP mRNA] | CTD | PMID:22228805 | benzo[a]pyrene | decreases methylation | ISO | PDE4DIP (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of PDE4DIP exon and Benzo(a)pyrene results in decreased methylation of PDE4DIP promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Benzo(a)pyrene metabolite results in decreased expression of PDE4DIP mRNA | CTD | PMID:32553695 | bisphenol A | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | bisphenol A results in increased expression of PDE4DIP mRNA | CTD | PMID:20678512 and PMID:29275510 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PDE4DIP mRNA | CTD | PMID:32145629 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of PDE4DIP gene | CTD | PMID:28505145 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PDE4DIP mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PDE4DIP mRNA | CTD | PMID:18180321 | bisphenol F | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PDE4DIP mRNA | CTD | PMID:28628672 | butanal | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of PDE4DIP mRNA | CTD | PMID:26079696 | C60 fullerene | affects expression | EXP | | 6480464 | fullerene C60 affects the expression of PDE4DIP mRNA | CTD | PMID:19167457 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of PDE4DIP mRNA | CTD | PMID:33453195 | cantharidin | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Cantharidin results in decreased expression of PDE4DIP mRNA | CTD | PMID:36907384 | carbon nanotube | affects expression | ISO | Pde4dip (Mus musculus) | 6480464 | Nanotubes and Carbon affects the expression of PDE4DIP mRNA | CTD | PMID:25554681 | carbon nanotube | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of PDE4DIP mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PDE4DIP gene] | CTD | PMID:28238834 | choline | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PDE4DIP mRNA | CTD | PMID:20938992 | clofibrate | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Clofibrate results in decreased expression of PDE4DIP mRNA | CTD | PMID:23811191 | clothianidin | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | clothianidin results in increased expression of PDE4DIP mRNA | CTD | PMID:31626844 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of PDE4DIP mRNA | CTD | PMID:24386269 | cocaine | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Cocaine results in decreased expression of PDE4DIP mRNA | CTD | PMID:16710320 | crocidolite asbestos | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Asbestos and Crocidolite affects the expression of PDE4DIP mRNA | CTD | PMID:25757056 | cyclosporin A | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of PDE4DIP mRNA | CTD | PMID:20106945 | dexamethasone | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PDE4DIP mRNA | CTD | PMID:28628672 | diarsenic trioxide | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of PDE4DIP mRNA | CTD | PMID:15761015 | diarsenic trioxide | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] affects the expression of PDE4DIP mRNA | CTD | PMID:15894607 | dorsomorphin | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of PDE4DIP mRNA | CTD | PMID:29803840 | entinostat | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | entinostat results in increased expression of PDE4DIP mRNA | CTD | PMID:27188386 | enzyme inhibitor | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PDE4DIP protein | CTD | PMID:23301498 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of PDE4DIP mRNA | CTD | PMID:20655511 | ethanol | affects splicing | ISO | Pde4dip (Mus musculus) | 6480464 | Ethanol affects the splicing of PDE4DIP mRNA | CTD | PMID:30319688 | ethanol | affects expression | ISO | Pde4dip (Mus musculus) | 6480464 | Ethanol affects the expression of PDE4DIP mRNA | CTD | PMID:26730594 | fenthion | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Fenthion results in decreased expression of PDE4DIP mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | increases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Folic Acid results in increased expression of PDE4DIP mRNA | CTD | PMID:25629700 | FR900359 | affects phosphorylation | ISO | PDE4DIP (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of PDE4DIP protein | CTD | PMID:37730182 | geldanamycin | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | geldanamycin results in increased expression of PDE4DIP mRNA | CTD | PMID:26705709 | genistein | increases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Genistein results in increased expression of PDE4DIP mRNA | CTD | PMID:32186404 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of PDE4DIP mRNA | CTD | PMID:33387578 | heroin | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Heroin results in increased expression of PDE4DIP mRNA | CTD | PMID:16710320 | indometacin | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PDE4DIP mRNA | CTD | PMID:28628672 | inulin | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PDE4DIP mRNA | CTD | PMID:36331819 | L-methionine | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PDE4DIP mRNA | CTD | PMID:20938992 | lead diacetate | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in increased expression of PDE4DIP mRNA | CTD | PMID:22839698 | lead(0) | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Lead results in decreased expression of PDE4DIP mRNA | CTD | PMID:19921347 | lead(0) | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Lead affects the expression of PDE4DIP mRNA | CTD | PMID:28903495 | mercury atom | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Mercury results in increased expression of PDE4DIP mRNA | CTD | PMID:16823088 | mercury(0) | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Mercury results in increased expression of PDE4DIP mRNA | CTD | PMID:16823088 | methamphetamine | increases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Methamphetamine results in increased expression of PDE4DIP mRNA | CTD | PMID:26307267 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of PDE4DIP gene | CTD | PMID:35440735 | methyl methanesulfonate | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of PDE4DIP mRNA | CTD | PMID:23649840 | N(4)-hydroxycytidine | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | N(4)-hydroxycytidine results in decreased expression of PDE4DIP mRNA | CTD | PMID:37748715 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of PDE4DIP gene | CTD | PMID:33148267 | nickel atom | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Nickel results in decreased expression of PDE4DIP mRNA | CTD | PMID:12540486 | nickel atom | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Nickel results in decreased expression of PDE4DIP mRNA | CTD | PMID:25583101 | nickel sulfate | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of PDE4DIP mRNA | CTD | PMID:22714537 | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of PDE4DIP mRNA | CTD | PMID:22124623 | panobinostat | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | panobinostat results in increased expression of PDE4DIP mRNA | CTD | PMID:26272509 | paracetamol | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of PDE4DIP mRNA | CTD | PMID:21420995 | paracetamol | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Acetaminophen affects the expression of PDE4DIP mRNA | CTD | PMID:25458485 | PCB138 | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | pentanal | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | pentanal results in increased expression of PDE4DIP mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PDE4DIP mRNA more ... | CTD | PMID:36331819 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of PDE4DIP gene | CTD | PMID:33148267 | phenylmercury acetate | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of PDE4DIP mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mRNA | CTD | PMID:27188386 | pirinixic acid | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of PDE4DIP mRNA | CTD | PMID:23811191 | potassium dichromate | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of PDE4DIP mRNA | CTD | PMID:23608068 | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of PDE4DIP mRNA | CTD | PMID:20726854 | propanal | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of PDE4DIP mRNA | CTD | PMID:26079696 | SB 431542 | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of PDE4DIP mRNA and Silicon Dioxide results in increased expression of PDE4DIP mRNA | CTD | PMID:23806026 and PMID:25351596 | sodium arsenite | affects methylation | ISO | PDE4DIP (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of PDE4DIP gene | CTD | PMID:28589171 | succimer | multiple interactions | ISO | Pde4dip (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDE4DIP mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PDE4DIP mRNA | CTD | PMID:21641980 and PMID:26378955 | tert-butyl hydroperoxide | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of PDE4DIP mRNA | CTD | PMID:15336504 | testosterone enanthate | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of PDE4DIP mRNA | CTD | PMID:17440010 | thapsigargin | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of PDE4DIP mRNA | CTD | PMID:24247028 | titanium dioxide | decreases expression | ISO | Pde4dip (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of PDE4DIP mRNA | CTD | PMID:23557971 | triacsin C | decreases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | triacsin C results in decreased expression of PDE4DIP mRNA | CTD | PMID:16704987 | Tributyltin oxide | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | bis(tri-n-butyltin)oxide affects the expression of PDE4DIP mRNA | CTD | PMID:24247028 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of PDE4DIP gene | CTD | PMID:27618143 | trichostatin A | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | trichostatin A results in increased expression of PDE4DIP mRNA | CTD | PMID:24935251 more ... | trichostatin A | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | trichostatin A affects the expression of PDE4DIP mRNA | CTD | PMID:28542535 | trichostatin A | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mRNA | CTD | PMID:27188386 | urethane | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Urethane results in increased expression of PDE4DIP mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | ISO | PDE4DIP (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of PDE4DIP gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PDE4DIP mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mRNA | CTD | PMID:27188386 | valproic acid | affects expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PDE4DIP mRNA | CTD | PMID:25979313 | valproic acid | affects expression | ISO | Pde4dip (Mus musculus) | 6480464 | Valproic Acid affects the expression of PDE4DIP mRNA | CTD | PMID:17963808 | vanadyl sulfate | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | vanadyl sulfate results in increased expression of PDE4DIP mRNA | CTD | PMID:16330358 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of PDE4DIP mRNA | CTD | PMID:19015723 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of PDE4DIP gene | CTD | PMID:31079544 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of PDE4DIP mRNA | CTD | PMID:23034163 | vorinostat | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDE4DIP mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | vorinostat results in increased expression of PDE4DIP mRNA | CTD | PMID:26272509 | zinc atom | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Zinc deficiency results in increased expression of PDE4DIP mRNA | CTD | PMID:18356318 | zinc protoporphyrin | multiple interactions | ISO | PDE4DIP (Homo sapiens) | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in increased expression of PDE4DIP mRNA | CTD | PMID:22839698 | zinc(0) | increases expression | ISO | PDE4DIP (Homo sapiens) | 6480464 | Zinc deficiency results in increased expression of PDE4DIP mRNA | CTD | PMID:18356318 | |
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
